Geriatric Considerations in the Management of Heart Failure and Arrhythmias: How to Deal With Cognitive Impairment, Frailty and ICD Deactivation at the End of Life?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Geriatric Considerations in the Management of Heart Failure and Arrhythmias: How to Deal With Cognitive Impairment, Frailty and ICD Deactivation at the End of Life?

By Scripps Health FEATURING John Dodson

17 views

July 7, 2021

0 Comments

Insights into Advances in Nonvalvular Atrial Fibrillation: Exploring…

Feat. C. Ruff, J. Walker

34:24

The France Foundation

Insights into Advances in Nonvalvular Atrial Fibrillation: Creating …

Feat. C. Ruff

11:37

ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich

14:39

Lankenau

Management of AF patients with ACS

Feat. P. Kowey, D. Ice

18:36

The Texas Heart Institute

Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?

Feat. M. Razavi

57:30

McMaster University Department of Medicine

Five Things Every Internist Should Know About Anticoagulants

Feat. S. Mithoowani

18:00

ACC 2023 Conference Coverage

ACC 2023: Catch Them Before They Fall - Syncope Guidelines in Action

Feat. B. Olshansky

09:50

The Cardiogenic Shock Working Group

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

Feat. N. Kapur

24:29

University of Miami

Anticoagulating the Challenging Atrial Fibrillation Patient

Feat. N. Sur

48:35

Houston Methodist DeBakey Heart and Vascular Center

"Pill in Pocket" Anticoagulation for Atrial Fibrillation: …

Feat. R. Passman

17:36

Mount Sinai Advanced Innovations in Heart Failure

Contemporary Management of Cardiogenic Shock: Updates in 2022

Feat. D. Baran

20:59

UChicago Medicine

Timing and Choice of Percutaneous Mechanical Circulatory Support (pM…

Feat. S. Nathan

13:53

American Heart & Vascular Institute

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

Feat. M. Ansari

01:19

Boston Scientific

HEMOCOAT™ Technology: Mechanism of Action

Feat. A. Finn

65:03

Abiomed

TNL a Closer Look at Operationalizing a Heart Team Approach

Feat. J. Rommel, P. Kane

06:03

Boston Scientific

HEMOCOAT™ Overview with Dr. Nielsen-Kudsk

Feat. J. Erik Nielsen-Kudsk

16:31

Courage and Innovation Symposium: Heart Failure & Heart Transplantation

Cardiac Sarcoidosis: Improving Diagnosis and Management

Feat. B. Chung

13:26

Boston Scientific

HEMOCOAT™ Technology: Experimental Overview

Feat. A. Finn

15:15

Joseph Thomas

The Other Option for Hemodynamic Support in High Risk PCI

14:36

Abiomed

CAMP - Impella RP in RV Shock Case - Tanmay Swadia, Michigan Heart

Feat. T. Swadia

Login

Login

Join VuMedi

Geriatric Considerations in the Management of Heart Failure and Arrhythmias: How to Deal With Cognitive Impairment, Frailty and ICD Deactivation at the End of Life?

Related Content